Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daryl K. Najarian"'
Autor:
Jerry Green, Richard A. Petruschke, Robert A. Moidel, Alan K. Matsumoto, Daryl K. Najarian, Alan Kivitz, Mary E. Dixon, Stanley Cohen, Adam B. Polis, Gregory P. Geba, Herbert S. B. Baraf, Maria Greenwald
Publikováno v:
Journal of the American Geriatrics Society. 52:666-674
To evaluate the use of starting doses of rofecoxib and nabumetone in patients with osteoarthritis (OA) of the knee.A 6-week, randomized, parallel-group, double-blind, placebo-controlled study.One hundred thirteen outpatient sites in the United States
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3052b08eba1ecfb59a1add5d97c80067
https://doi.org/10.1111/j.1532-5415.2004.52201.x
https://doi.org/10.1111/j.1532-5415.2004.52201.x
Autor:
Daryl K. Najarian, Gregory P. Geba, John Londoño, Bernard R. Rubin, Zafer E. Ozturk, Sandra V. Navarra, Richard A. Petruschke, Keith G. Pryhuber, Robert Burton, Joseph Antigua, Erluo Chen, Margaret Lund
Publikováno v:
Arthritis & Rheumatism. 50:598-606
Objective To evaluate the efficacy and safety of etoricoxib and indomethacin in the treatment of patients with acute gout. Methods A randomized, double-blind, active-comparator study was conducted at 42 sites. A total of 189 men and women (≥18 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::914306365752745fe0f71564a738788f
https://doi.org/10.1002/art.20007
https://doi.org/10.1002/art.20007
Autor:
Daryl K. Najarian, Arthur L. Weaver, Gregory P. Geba, Adam B. Polis, Richard A. Petruschke, Ronald P. Messner, William W. Storms, Andrew M. Tershakovec
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 12(1)
Rofecoxib and nabumetone were developed to provide gastrointestinal benefits over traditional nonsteroidal antiinflammatory drugs (NSAIDs). However, there is limited comparative information relating to these 2 drugs.The objective of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62b5c4efd1e1b75d3428bae517af2b8
https://pubmed.ncbi.nlm.nih.gov/16484875
https://pubmed.ncbi.nlm.nih.gov/16484875
Autor:
Alan J, Kivitz, Maria W, Greenwald, Stanley B, Cohen, Adam B, Polis, Daryl K, Najarian, Mary E, Dixon, Robert A, Moidel, Jerry A, Green, Herbert S B, Baraf, Richard A, Petruschke, Alan K, Matsumoto, Gregory P, Geba
Publikováno v:
Journal of the American Geriatrics Society. 52(5)
To evaluate the use of starting doses of rofecoxib and nabumetone in patients with osteoarthritis (OA) of the knee.A 6-week, randomized, parallel-group, double-blind, placebo-controlled study.One hundred thirteen outpatient sites in the United States
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c67430a8a96025462fe5c73b0dc7b0b5
https://pubmed.ncbi.nlm.nih.gov/15086644
https://pubmed.ncbi.nlm.nih.gov/15086644
Autor:
Bernard R, Rubin, Robert, Burton, Sandra, Navarra, Joseph, Antigua, John, Londoño, Keith G, Pryhuber, Margaret, Lund, Erluo, Chen, Daryl K, Najarian, Richard A, Petruschke, Zafer E, Ozturk, Gregory P, Geba
Publikováno v:
Arthritis and rheumatism. 50(2)
To evaluate the efficacy and safety of etoricoxib and indomethacin in the treatment of patients with acute gout.A randomized, double-blind, active-comparator study was conducted at 42 sites. A total of 189 men and women (or =18 years of age) who were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8dea436f4b7c1dcee843df7259ca50d7
https://pubmed.ncbi.nlm.nih.gov/14872504
https://pubmed.ncbi.nlm.nih.gov/14872504